Matisse Capital’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,917
Closed -$14.5K 180
2023
Q1
$14.5K Hold
2,917
0.01% 175
2022
Q4
$14.1K Hold
2,917
0.01% 130
2022
Q3
$30K Hold
2,917
0.04% 83
2022
Q2
$41K Hold
2,917
0.04% 122
2022
Q1
$49K Hold
2,917
0.05% 122
2021
Q4
$72K Hold
2,917
0.05% 132
2021
Q3
$108K Hold
2,917
0.04% 142
2021
Q2
$142K Hold
2,917
0.04% 140
2021
Q1
$86K Sell
2,917
-500
-15% -$14K 0.02% 163
2020
Q4
$87K Sell
3,417
-416
-11% -$8.36K 0.03% 152
2020
Q3
$56K Sell
3,833
-3,834
-50% -$63.5K 0.02% 143
2020
Q2
$158K Sell
7,667
-2,500
-25% -$66.1K 0.05% 143
2020
Q1
$322K Buy
+10,167
New +$255K 0.13% 130

Other funds holding VSTM

Matisse Capital's VSTM Position: Q2 2023 in Review

Matisse Capital sold out of Verastem (VSTM) in Q2 2023, closing a stake of 2,917 shares — an estimated $14.5K sold.

Matisse Capital first reported a position in VSTM in Q1 2020 and held it in 13 quarters. The position peaked at $322K in Q1 2020. 61 funds tracked by Wall St. Rank hold VSTM as of Q2 2023.

  • Matisse Capital reported no remaining Verastem position as of Q2 2023 after selling out during the quarter.
  • Matisse Capital sold 2,917 Verastem shares in Q2 2023, an estimated $14.5K.
  • Matisse Capital first reported a position in Verastem in Q1 2020 and held it in 13 quarters.
  • Matisse Capital's Verastem position peaked at $322K in Q1 2020.
  • 61 funds tracked by Wall St. Rank held Verastem as of Q2 2023.

Based on Matisse Capital's 13F filing for Q2 2023, filed 2 Aug 2023.